Literature DB >> 21901259

Erythrocyte deformability and oxidative stress in inflammatory bowel disease.

Tulay Akman1, Mesut Akarsu, Hale Akpinar, Halil Resmi, Ebru Taylan, Ebru Sezer.   

Abstract

BACKGROUND: Oxidative stress and reduced microvascular flow are important factors in the pathogenesis of inflammatory bowel disease (IBD). The increased oxidative stress reduces the erythrocyte deformability. However, in IBD, there are no studies in the literature which evaluate erythrocyte deformability. AIMS: In our study, we investigated the effect of oxidative stress and erythrocyte deformability in IBD.
METHODS: Forty-three patients with active IBD, 48 patients with inactive IBD and 45 healthy controls were included. The erytrocyte deformability, malonyldialdehyde levels, glutation peroxidase and sulfhydryl levels were measured in peripheral venous blood samples.
RESULTS: Erytrocyte malonyldialdehyde levels in both active and inactive IBD were significantly increased compared with control groups. Plasma glutation peroxidase levels did not show statistically significant difference between all groups. The decreased plasma sulfhydryl levels in active IBD were statistically significant compared with both the inactive IBD and the control group, but plasma sulfhydryl levels in inactive IBD group did not show statistically significant differences when compared with the control group. Elongation index values in both active and inactive IBD increased significantly compared with the control group. Statistically significant correlations were not found between the elongation index and glutation peroxidase, malonyldialdehyde, sulfhydryl levels in all groups.
CONCLUSIONS: Our study is the first to evaluate the erythrocyte deformability in IBD. In our study, increased erytrocyte malonyldialdehyde levels and decreased plasma sulfhydryl levels manifested the role of oxidative stress in the pathogenesis of the disease. It is thought that the increased erythrocyte malonyldialdehyde values cause the reduction in erythrocyte deformability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901259     DOI: 10.1007/s10620-011-1882-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  46 in total

1.  Total antioxidant capacity of colon in patients with chronic ulcerative colitis.

Authors:  T R Koch; L X Yuan; S J Stryker; P Ratliff; G L Telford; E C Opara
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

2.  Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy.

Authors:  Walter Fries; Maria C Renda; Maria A Lo Presti; Antonella Raso; Ambrogio Orlando; Lorenzo Oliva; Maria R Giofré; Aurelio Maggio; Anna Mattaliano; Alfredo Macaluso; Mario Cottone
Journal:  Am J Gastroenterol       Date:  2005-12       Impact factor: 10.864

3.  Advanced oxidation protein products: a novel marker of oxidative stress in ulcerative colitis.

Authors:  Mevlut Baskol; Gulden Baskol; Derya Koçer; Omer Ozbakir; Mehmet Yucesoy
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

4.  Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression.

Authors:  E M Conner; S J Brand; J M Davis; D Y Kang; M B Grisham
Journal:  Inflamm Bowel Dis       Date:  1996       Impact factor: 5.325

Review 5.  The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.

Authors:  Ossama A Hatoum; Jan Heidemann; David G Binion
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

6.  Depleted mucosal antioxidant defences in inflammatory bowel disease.

Authors:  G D Buffinton; W F Doe
Journal:  Free Radic Biol Med       Date:  1995-12       Impact factor: 7.376

7.  Oxidant-induced disruption of intestinal epithelial barrier function: role of protein tyrosine phosphorylation.

Authors:  R K Rao; R D Baker; S S Baker; A Gupta; M Holycross
Journal:  Am J Physiol       Date:  1997-10

8.  Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.

Authors:  Laurens Kruidenier; Ineke Kuiper; Wim Van Duijn; Marij A C Mieremet-Ooms; Ruud A van Hogezand; Cornelis B H W Lamers; Hein W Verspaget
Journal:  J Pathol       Date:  2003-09       Impact factor: 7.996

9.  Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease.

Authors:  W J Angerson; M C Allison; J N Baxter; R I Russell
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

Review 10.  Red blood cell rheology in sepsis.

Authors:  M Piagnerelli; K Zouaoui Boudjeltia; M Vanhaeverbeek; J-L Vincent
Journal:  Intensive Care Med       Date:  2003-06-12       Impact factor: 17.440

View more
  10 in total

1.  Different profile of peripheral antioxidant enzymes and lipid peroxidation in active and non-active inflammatory bowel disease patients.

Authors:  D Achitei; A Ciobica; G Balan; E Gologan; C Stanciu; G Stefanescu
Journal:  Dig Dis Sci       Date:  2013-01-11       Impact factor: 3.199

2.  L-carnosine alters some hemorheologic and lipid peroxidation parameters in nephrectomized rats.

Authors:  Hande Yapislar; Eylem Taskin
Journal:  Med Sci Monit       Date:  2014-03-11

3.  Effects of Glutamine and Omega-3 Fatty Acids on Erythrocyte Deformability and Oxidative Damage in Rat Model of Enterocolitis.

Authors:  Ruksan Cehreli; Hale Akpinar; Aysegul Temiz Artmann; Ozgul Sagol
Journal:  Gastroenterology Res       Date:  2015-10-21

4.  Haemorheological and haemostatic alterations in coeliac disease and inflammatory bowel disease in comparison with non-coeliac, non-IBD subjects (HERMES): a case-control study protocol.

Authors:  Péter Hegyi; Judit Bajor; Zsolt Szakács; Beáta Csiszár; Péter Kenyeres; Patrícia Sarlós; Bálint Erőss; Alizadeh Hussain; Ágnes Nagy; Balázs Kőszegi; Ibolya Veczák; Nelli Farkas; Emőke Bódis; Katalin Márta; Andrea Szentesi; Margit Tőkés-Füzesi; Tímea Berki; Áron Vincze; Kálmán Tóth
Journal:  BMJ Open       Date:  2019-03-23       Impact factor: 2.692

5.  Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease.

Authors:  Arno R Bourgonje; Ruben Y Gabriëls; Martin H de Borst; Marian L C Bulthuis; Klaas Nico Faber; Harry van Goor; Gerard Dijkstra
Journal:  Antioxidants (Basel)       Date:  2019-09-01

6.  Experimental Data-Mining Analyses Reveal New Roles of Low-Intensity Ultrasound in Differentiating Cell Death Regulatome in Cancer and Non-cancer Cells via Potential Modulation of Chromatin Long-Range Interactions.

Authors:  Jiwei Wang; Bin Lai; Gayani Nanayakkara; Qian Yang; Yu Sun; Yifan Lu; Ying Shao; Daohai Yu; William Y Yang; Ramon Cueto; Hangfei Fu; Huihong Zeng; Wen Shen; Susu Wu; Chunquan Zhang; Yanna Liu; Eric T Choi; Hong Wang; Xiaofeng Yang
Journal:  Front Oncol       Date:  2019-07-12       Impact factor: 6.244

Review 7.  Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Juliana Célia Farias Dos Santos; Orlando Roberto Pimentel Araújo; Marília Oliveira Fonseca Goulart
Journal:  Redox Biol       Date:  2015-10-23       Impact factor: 11.799

Review 8.  Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to Unravel.

Authors:  Inés Moret-Tatay; Marisa Iborra; Elena Cerrillo; Luis Tortosa; Pilar Nos; Belén Beltrán
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

9.  Colonic and Hepatic Modulation by Lipoic Acid and/or N-Acetylcysteine Supplementation in Mild Ulcerative Colitis Induced by Dextran Sodium Sulfate in Rats.

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Orlando Roberto Pimentel de Araújo; Valéria Nunes-Souza; Juliana Célia de Farias Santos; Luiza Antas Rabelo; Marília Oliveira Fonseca Goulart
Journal:  Oxid Med Cell Longev       Date:  2016-11-13       Impact factor: 6.543

10.  Diet-Dependent and Diet-Independent Hemorheological Alterations in Celiac Disease: A Case-Control Study.

Authors:  Zsolt Szakács; Beáta Csiszár; Mátyás Nagy; Nelli Farkas; Péter Kenyeres; Adrienn Erős; Alizadeh Hussain; Katalin Márta; Andrea Szentesi; Margit Tőkés-Füzesi; Tímea Berki; Áron Vincze; Kálmán Tóth; Péter Hegyi; Judit Bajor
Journal:  Clin Transl Gastroenterol       Date:  2020-11       Impact factor: 4.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.